Evaluation of Hand Grip Strength in Pregnant COVID-19 Patients

Musculoskeletal Pain in Pregnant Infected With COVID-19, Evaluation of Fatigue and Muscle Grip Strength

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05970874

Enrollment

Registered

2023-08-01

Start date

2021-12-01

Completion date

2022-05-30

Last updated

2023-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Pregnancy Related

Keywords

COVID-19, Musculoskeletal Symptom, Hand Grip Muscle Streng

Brief summary

It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Detailed description

Covid 19 is the disease defined for strains infected with severe acute respiratory syndrome coronavirus 2(Sars-CoV-2). Hand grip strength is a non-invasive, easily applicable, objective parameter. It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Interventions

DEVICEHand grip strength measureme

Hand grip strength (HSG) was measured in kg with the CAMRY Digital Hand Dynamometer (Model No. EH101, CAMRY).

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19

Exclusion criteria

* Those with orthopedic defects in the dominant hand and wrist and those with hand, wrist and shoulder involvement on the side of the measurement related to rheumatological diseases were excluded from the study.

Design outcomes

Primary

Measure	Time frame	Description
Hand grip strength assessment	The first 24 hours after admission to the service.	Hand grip strength assessment in pregnancy Covid 19.

Secondary

Measure	Time frame	Description
symptoms	The first 24 hours after admission to the service.	Common symptoms of pregnant Covid 19 patients.
laboratory findings	The first 24 hours after admission to the service.	Common laboratory findings of pregnant Covid 19 patients.
Vaccine	pre-infection period was questioned	Vaccine rate of pregnant Covid 19 patients.
Smoking	pre-infection period was questioned	Smoking rate of pregnant Covid 19 patients.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026